Serum concentration of visfatin in obese women

Metabolism: Clinical and Experimental

Volumn 56, Issue 8, 2007, Pages 1131-1134

  Zahorska Markiewicz, Barbara ^a   Olszanecka Glinianowicz, Magdalena ^a   Janowska, Joanna ^a   Kocełak, Piotr ^a   Semik Grabarczyk, Elzbieta ^a   Holecki, Michał ^a   Dabrowski, Piotr ^a   Skorupa, Anna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; VISFATIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; TRIGLYCERIDES;

EID: 34347402227     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.04.007     Document Type: Article

References (13)

1. Juge-Aubry C.E., Henrichot E., and Meier C.A. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19 (2005) 547-566
2. Rajala M.W., and Scherer P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
3. Zahorska-Markiewicz B., Janowska J., Olszanecka-Glinianowicz M., et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 24 (2000) 1329-1395
4. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Janowska J., et al. Serum concentrations of nitric oxide, TNF-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism 53 (2004) 1268-1273
5. Varma V., Yao-Borengasser A., Rasouli N., et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipid and inflammation. J Clin Endocrinol Metab (2006) as doi:10.1012/jc.2006-1303
6. Fukuhara A., Matsuda M., Nishizawa M., et al. Visfatin: a protein secreted by visceral fat that mimics the effect of insulin. Science 307 (2005) 426-430
7. Berndt J., Klöting N., Kralisch S., Kovacs P., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
8. Hammarstedt A., Pihlajamaki J., Sopasakis V.R., et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91 (2006) 1181-1184
9. Haider D.G., Schindler K., Schaller G., et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91 (2006) 1578-1581
10. Pagano C., Pilon C., Olivieri M., et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91 (2006) 3165-3170
11. Chen M.P., Chung F.M., Chang D.M., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 28-30
12. Kralisch S., Klein J., Lossner U., et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289 (2005) E586-E590
13. Kralisch S., Klein J., Lossner U., et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185 (2005) R1-R8